Ad
related to: how to use testo 405i digital
Search results
Results From The WOW.Com Content Network
In 1964, the BBC launched its BBC2 service on UHF using only a 625-line system, which older sets could not receive. For several years BBC1 and ITV transmitted using the 405-line and BBC2 with the 625-line standard; the only way to receive them all was to use a complex "dual-standard" 405- and 625-line, VHF and UHF, receiver. The introduction of ...
Testo SE & Co. KGaA is a company from Lenzkirch, founded in 1957, with its headquarters in Titisee-Neustadt, Germany. The company has 35 subsidiary firms in China, Japan, Korea, USA, France, Spain, Italy, and other countries and employs around 3200 people. 1700 alone at its sites in Lenzkirch, Kirchzarten , and Titisee.
Testosterone propionate was discovered in 1936 and was introduced for medical use in 1937. [ 12 ] [ 4 ] It was the first testosterone ester to be marketed, and was the major form of testosterone used in medicine until about 1960.
Testosterone is a medication and naturally occurring steroid hormone. [9] It is used to treat male hypogonadism, gender dysphoria, and certain types of breast cancer. [9] [10] It may also be used to increase athletic ability in the form of doping. [9]
Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men, [2] [3] [4] including hormone therapy for transgender men.
The four testosterone esters are as follows; . 30 mg testosterone propionate [1]; 60 mg testosterone phenylpropionate [1]; 60 mg testosterone isocaproate [1]; 100 mg testosterone decanoate [1]
Testosterone enanthate is used primarily in androgen replacement therapy. [4] [15] It is the most widely used form of testosterone in androgen replacement therapy. [4]The medication is specifically approved, in the United States, for the treatment of hypogonadism in men, delayed puberty in boys, and breast cancer in women. [16]
Testosterone undecanoate was introduced in China for use by injection and in the European Union for use by mouth in the 1970s. [18] [19] It became available for use by injection in the European Union in the early to mid 2000s and in the United States in 2014. [20] [21] Formulations for use by mouth are approved in the United States.